Literature DB >> 28780013

American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.

Joseph D Feuerstein1, Geoffrey C Nguyen2, Sonia S Kupfer3, Yngve Falck-Ytter4, Siddharth Singh5.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28780013     DOI: 10.1053/j.gastro.2017.07.032

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  127 in total

1.  A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.

Authors:  David T Rubin; Cindy Traboulsi; Victoria Rai
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-02

2.  Positioning Biologic Therapies in the Management of Pediatric Inflammatory Bowel Disease.

Authors:  Jessica Breton; Arthur Kastl; Maire A Conrad; Robert N Baldassano
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-08

Review 3.  Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.

Authors:  Nicholas Carman; David R Mack; Eric I Benchimol
Journal:  Curr Gastroenterol Rep       Date:  2018-04-05

4.  New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases.

Authors:  Benjamin Nemoz; David Ternant; Sébastien Bailly; Elodie Gautier-Veyret; Jean-François Jourdil; Bruno Bonaz; Françoise Stanke-Labesque
Journal:  Br J Clin Pharmacol       Date:  2019-01-28       Impact factor: 4.335

5.  Adalimumab in Psoriasis: How Much Is Enough?

Authors:  Allison C Billi; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2019-01       Impact factor: 8.551

Review 6.  Therapy for Crohn's Disease: a Review of Recent Developments.

Authors:  Gregory J Eustace; Gil Y Melmed
Journal:  Curr Gastroenterol Rep       Date:  2018-04-05

7.  Therapeutics for Inflammatory Bowel Diseases in Children and Adolescents: A Focus on Biologics and an Individualized Treatment Paradigm.

Authors:  Suruchi Batra; Laurie S Conklin
Journal:  Handb Exp Pharmacol       Date:  2020

8.  Going Third Class: Treatment of Steroid-Dependent Ulcerative Colitis.

Authors:  Helen Lee; Yecheskel Schneider; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2019-05       Impact factor: 3.199

9.  Improving IBD Care: A Personalized Approach to Management.

Authors:  Stephen B Hanauer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

Review 10.  Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.

Authors:  Miles P Sparrow; Konstantinos Papamichael; Mark G Ward; Pauline Riviere; David Laharie; Stephane Paul; Xavier Roblin
Journal:  J Crohns Colitis       Date:  2020-05-21       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.